Plasma levels of syndecan-4 (ryudocan) are elevated in patients with acute myocardial infarction

Thrombosis and Haemostasis

Volumn 85, Issue 5, 2001, Pages 793-799

  Kojima, T ^a   Takagi, A ^a   Maeda, M ^a   Segawa, T ^a   Shimizu, A ^a   Yamamoto, K ^a   Matsushita, T ^a   Saito, H ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Enzyme linked immuno sorbent assay (ELISA); Hypoxia; Syndecan 4 (ryudocan); Tissue repair

Indexed keywords

ACETYLSALICYLIC ACID; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HEPARIN BINDING PROTEIN; SYNDECAN; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MEDIATOR; MOLECULE; NORTHERN BLOTTING; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TISSUE REPAIR;

EID: 0035020956     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615720     Document Type: Article

References (38)

1. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells
2. Molecular cloning and expression of two distinct cDNA encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line
3. Biology of the syndecans: A family of transmembrane haparan sulfate proteoglycans
4. Syndecans: Multifunctional cell-surface co-receptors
5. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widesrpread focal adhesion component
6. Protein kinase C regulates the recruitment of syndecan-4 into focal contacts
7. Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions
8. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns
9. Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor
10. Characterization of ryudocan glycosaminoglycan acceptor sites
11. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Ca
12. Mulimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C
13. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinattely regulate protein kinase C activity
14. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a prorine-rich antimicrobial peptide from wounds
15. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells
16. Macrophage-dependent regulation of syndecan gene expression
17. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
18. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
19. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
20. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
21. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304 → Trp); Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor
22. Human ryudocan core protein: Molecular cloning and characterization of the cDNA, and chromosomal localization of the gene
23. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms
24. Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool
25. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte
26. Molecular cloning, genomic organization, promoter activity, and tissue-specfic expression of the mouse ryudocan gene
27. Molecular cloning of syndecan, an integral membrane proteoglycan
28. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development
29. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences
30. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA
31. Diagnosis of hemophilia B carriers using two novel dinucleotide polymorphisms and Hha I RFLP of the factor IX gene in Japanese subjects
32. The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction
33. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation
34. Ischaemia-induced expression of βFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle
35. Myocardial infarction induces expression of midkine, a heparin-binding growth factor with reparative activity
36. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
37. Myocyte-dependent regulation of endothelial cell syndecan-4 expression
38. Syndecan-4 expression is associated with follicular atresia in mouse ovary